Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMcbride Regulatory News (MCB)

Share Price Information for Mcbride (MCB)

Share Price is delayed by 15 minutes
Get Live Data
159.00    -3.40 (-2.09%)
Bid:
159.00
Ask:
149.60
Spread: -9.40 (-5.912%)
Market Cap: £276.19m
MCB Live PriceLast checked at - London Stock Exchange

Intraday Mcbride Share Chart

Director Appointment

10 Mar 2026 07:00

RNS Number : 9495V
McBride PLC
10 March 2026
 

10 March 2026

McBride plc

Director Appointment

 

McBride plc (the 'Company'), the leading European manufacturer and supplier of private label and contract manufactured products for the domestic household and professional cleaning/hygiene markets, announces the appointment of Casper Meijer as an independent Non-Executive Director with effect from 10 March 2026. 

Casper has extensive experience in the retail sector across a wide range of categories, such as garden, pet, outdoor living, food, household goods and discount retail, in both local and international companies. He brings specific expertise in private label, category management and sustainable innovation.

Presently, Casper is the Chief Executive Officer of Welkoop, a Dutch retail chain that focuses on garden, pet and outdoor living products. In addition, Casper is a Non-Executive Director of Fiksuruoka, a Finnish company (which trades as Foodello outside of Finland) that has become one of the leading food‑waste‑reduction retailers in Europe. Previously, Casper was the Chief Executive Officer of Blokker Holding (now known as Mirage Retail Group), a Dutch retail conglomerate that has owned and operated many of the Netherlands' best‑known non‑food store chains. He has also held the position of Group Trading Director at Morrisons plc, the UK supermarket chain and was Commercial Director and Board member at Albert Heijn. Contemporaneously with joining the Board, Casper will become a member of the Audit and Risk, Nomination and Remuneration Committees of the Company.

McBride has been advised that there are no other details which require disclosure under UK Listing Rule 6.4.8. Casper does not have any interest in the shares of McBride.

Jeff Nodland, Chairman, said: "On behalf of the Board, I am delighted to welcome Casper to McBride. His wealth of experience, particularly in retail in mainland Europe, will further strengthen the Board. The Directors and I look forward to working with Casper as we continue to focus on the Company's key objectives in the months and years ahead."

 

ENDS

For further information, please contact:

 

McBride plc

via TEAM LEWIS

Jeff Nodland, Chairman

Chris Smith, Chief Executive Officer

 

 

Team Lewis

Hannah Scott

Galyna Kulachek

 

+44 20 7802 2634

+44 20 7802 2664

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUKRARNWUORUR
Date   Source Headline
1st Dec 20257:00 amRNSLaunch of share buyback programme
28th Nov 20256:29 pmRNSRedemption of B Shares and Total Voting Rights
27th Nov 202512:27 pmRNSHolding(s) in Company
25th Nov 20257:00 amRNSHolding(s) in Company
20th Nov 20254:40 pmRNSAGM Statement
20th Nov 20257:00 amRNSAGM Trading Update and Share Buyback
18th Nov 20259:42 amRNSHolding(s) in Company
31st Oct 20257:00 amRNSTotal Voting Rights
27th Oct 20257:00 amRNSHolding(s) in Company
23rd Oct 20256:15 pmRNSDirector/PDMR Shareholding
22nd Oct 20257:00 amRNSApplication for Additional Listing of Shares
17th Oct 20256:23 pmRNSDirector/PDMR Shareholding
2nd Oct 20257:00 amRNSAnnual Financial Report
24th Sep 20257:00 amRNSRedemption of B Shares
19th Sep 20257:00 amRNSDirector/PDMR Shareholding
18th Sep 20259:04 amRNSEx-dividend date - Correction
17th Sep 20257:00 amRNSFinal Results
5th Sep 20257:00 amRNS-RInvestor Webinar on 18 September 2025
16th Jul 20257:00 amRNSFull Year Trading Update
16th Jun 20257:00 amRNSDirector/PDMR Shareholding
10th Jun 20257:00 amRNSHolding(s) in Company
29th May 20253:19 pmRNSHolding(s) in Company
23rd May 20251:42 pmRNSHolding(s) in Company
19th May 20257:00 amRNSHolding(s) in Company
12th May 20257:00 amRNSHolding(s) in Company
6th May 20257:00 amRNSHolding(s) in Company
29th Apr 20257:00 amRNSHolding(s) in Company
22nd Apr 20257:00 amRNSHolding(s) in Company
8th Apr 20257:00 amRNSHolding(s) in Company
28th Feb 20255:00 pmRNSHolding(s) in Company
25th Feb 20257:00 amRNSHalf-year Report
18th Feb 20256:15 pmRNSHolding(s) in Company
11th Feb 20254:40 pmRNSHolding(s) in Company
17th Jan 20257:00 amRNSTrading Statement
29th Nov 20247:00 amRNSSuccessful Completion of Refinancing
18th Nov 20241:10 pmRNSDirector/PDMR Shareholding
18th Nov 20241:09 pmRNSDirector/PDMR Shareholding
15th Nov 20241:10 pmRNSDirector/PDMR Shareholding
12th Nov 20246:36 pmRNSResult of Annual General Meeting
12th Nov 20247:00 amRNSAGM Trading Update
6th Nov 20243:53 pmRNSDirector/PDMR Shareholding
31st Oct 20247:00 amRNSDirector/PDMR Shareholding
25th Oct 20243:48 pmRNSDirector/PDMR Shareholding
8th Oct 20246:25 pmRNSDirector/PDMR Shareholding
7th Oct 20247:00 amRNSAnnual Financial Report
1st Oct 20245:30 pmRNSDirector/PDMR Shareholding
26th Sep 20247:00 amRNSDirector/PDMR Shareholding
24th Sep 20243:38 pmRNSDirector/PDMR Shareholding
20th Sep 20245:17 pmRNSDirector/PDMR Shareholding
19th Sep 20247:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.